Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigator-initiated Single-center, Randomized, Double-blind, Placebo-controlled Clinical Study Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis

NCT07120308 is registered in ClinicalTrials.gov with Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. as lead sponsor.

NCT NCT07120308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07120308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigator-initiated Single-center, Randomized, Double-blind, Placebo-controlled Clinical Study Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis
Lead sponsor
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Phase
Phase 2
Overall status
Completed
Start date
September 15, 2021
Completion date
January 30, 2023
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corneal epithelial defect